{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:53:01Z","timestamp":1772941981788,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC2015-0283-1640540-1"],"award-info":[{"award-number":["NCC2015-0283-1640540-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11060-017-2717-0","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T10:45:25Z","timestamp":1513680325000},"page":"295-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis"],"prefix":"10.1007","volume":"137","author":[{"given":"Jaehag","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hye","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Shin","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-4300","authenticated-orcid":false,"given":"Heon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"issue":"2","key":"2717_CR1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4143\/crt.2016.089","volume":"48","author":"CM Oh","year":"2016","unstructured":"Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, Lee DH, Lee KH (2016) Community of population-based regional cancer R: cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 48(2):436\u2013450","journal-title":"Cancer Res Treat"},{"issue":"17","key":"2717_CR2","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","volume":"22","author":"NU Lin","year":"2004","unstructured":"Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22(17):3608\u20133617","journal-title":"J Clin Oncol"},{"issue":"3","key":"2717_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-007-9806-2","volume":"111","author":"SS Lee","year":"2008","unstructured":"Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK (2008) Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat 111(3):523\u2013530","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2717_CR4","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1093\/annonc\/mdr022","volume":"22","author":"E Brogi","year":"2011","unstructured":"Brogi E, Murphy CG, Johnson ML, Conlin AK, Hsu M, Patil S, Akram M, Nehhozina T, Jhaveri KL, Hudis CA et al (2011) Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays. Ann Oncol 22(12):2597\u20132603","journal-title":"Ann Oncol"},{"issue":"1","key":"2717_CR5","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr1870","volume":"10","author":"BH Nam","year":"2008","unstructured":"Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J (2008) Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res 10(1):R20","journal-title":"Breast Cancer Res"},{"issue":"7","key":"2717_CR6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bjc.2012.346","volume":"107","author":"YS Yap","year":"2012","unstructured":"Yap YS, Cornelio GH, Devi BC, Khorprasert C, Kim SB, Kim TY, Lee SC, Park YH, Sohn JH, Sutandyo N et al (2012) Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival. Br J Cancer 107(7):1075\u20131082","journal-title":"Br J Cancer"},{"issue":"5","key":"2717_CR7","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/bcr2645","volume":"12","author":"LD Hoefnagel","year":"2010","unstructured":"Hoefnagel LD, van de Vijver MJ, van Slooten HJ, Wesseling P, Wesseling J, Westenend PJ, Bart J, Seldenrijk CA, Nagtegaal ID, Oudejans J et al (2010) Receptor conversion in distant breast cancer metastases. Breast Cancer Res 12(5):R75","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2717_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-009-0720-7","volume":"123","author":"NU Lin","year":"2010","unstructured":"Lin NU (2010) Concordance of HER2 in primary tumor and leptomeningeal metastases: now what? Breast Cancer Res Treat 123(1):129\u2013131","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2717_CR9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/etm_00000088","volume":"1","author":"Y Omoto","year":"2010","unstructured":"Omoto Y, Kurosumi M, Hozumi Y, Oba H, Kawanowa K, Takei H, Yasuda Y (2010) Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis. Exp Ther Med 1(4):561\u2013567","journal-title":"Exp Ther Med"},{"issue":"4","key":"2717_CR10","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/bcr3244","volume":"14","author":"R Duchnowska","year":"2012","unstructured":"Duchnowska R, Dziadziuszko R, Trojanowski T, Mandat T, Och W, Czartoryska-Arlukowicz B, Radecka B, Olszewski W, Szubstarski F, Kozlowski W et al (2012) Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res 14(4):R119","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2717_CR11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2010.33.8889","volume":"30","author":"N Niikura","year":"2012","unstructured":"Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL, Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT (2012) Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors. J Clin Oncol 30(6):593\u2013599","journal-title":"J Clin Oncol"},{"issue":"4","key":"2717_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tbj.12596","volume":"22","author":"AB Kroigard","year":"2016","unstructured":"Kroigard AB, Larsen MJ, Thomassen M, Kruse TA (2016) Molecular concordance between primary breast cancer and matched metastases. Breast J 22(4):420\u2013430","journal-title":"Breast J"},{"issue":"3","key":"2717_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10555-016-9631-3","volume":"35","author":"C Yeung","year":"2016","unstructured":"Yeung C, Hilton J, Clemons M, Mazzarello S, Hutton B, Haggar F, Addison CL, Kuchuk I, Zhu X, Gelmon K et al (2016) Estrogen, progesterone, and HER2\/neu receptor discordance between primary and metastatic breast tumours-a review. Cancer Metastasis Rev 35(3):427\u2013437","journal-title":"Cancer Metastasis Rev"},{"issue":"21","key":"2717_CR14","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.2011.37.2482","volume":"30","author":"LS Lindstrom","year":"2012","unstructured":"Lindstrom LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, Hatschek T, Skoog L, Bergh J (2012) Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol 30(21):2601\u20132608","journal-title":"J Clin Oncol"},{"issue":"6","key":"2717_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2010.33.5232","volume":"30","author":"E Amir","year":"2012","unstructured":"Amir E, Miller N, Geddie W, Freedman O, Kassam F, Simmons C, Oldfield M, Dranitsaris G, Tomlinson G, Laupacis A et al (2012) Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol 30(6):587\u2013592","journal-title":"J Clin Oncol"},{"issue":"1","key":"2717_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/mdn539","volume":"20","author":"IH Park","year":"2009","unstructured":"Park IH, Ro J, Lee KS, Nam BH, Kwon Y, Shin KH (2009) Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer. Ann Oncol 20(1):56\u201362","journal-title":"Ann Oncol"},{"issue":"5","key":"2717_CR17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.2010.12","volume":"87","author":"EC Dijkers","year":"2010","unstructured":"Dijkers EC, Oude Munnink TH, Kosterink JG, Brouwers AH, Jager PL, de Jong JR, van Dongen GA, Schroder CP, Lub-de Hooge MN, de Vries EG (2010) Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin Pharmacol Ther 87(5):586\u2013592","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2717_CR18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/annonc\/mdu133","volume":"25","author":"SM Swain","year":"2014","unstructured":"Swain SM, Baselga J, Miles D, Im YH, Quah C, Lee LF, Cortes J (2014) Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. Ann Oncol 25(6):1116\u20131121","journal-title":"Ann Oncol"},{"issue":"1","key":"2717_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/mdu486","volume":"26","author":"IE Krop","year":"2015","unstructured":"Krop IE, Lin NU, Blackwell K, Guardino E, Huober J, Lu M, Miles D, Samant M, Welslau M, Dieras V (2015) Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA. Ann Oncol 26(1):113\u2013119","journal-title":"Ann Oncol"},{"issue":"8","key":"2717_CR20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/modpathol.3800830","volume":"20","author":"J Gaedcke","year":"2007","unstructured":"Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe HH (2007) Predominance of the basal type and HER-2\/neu type in brain metastasis from breast cancer. Mod Pathol 20(8):864\u2013870","journal-title":"Mod Pathol"},{"issue":"2","key":"2717_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-008-9654-x","volume":"90","author":"K Yonemori","year":"2008","unstructured":"Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hashizume K, Ono M, Nakanishi Y, Hasegawa T, Miyakita Y, Narita Y et al (2008) Immunohistochemical profiles of brain metastases from breast cancer. J Neuro-Oncol 90(2):223\u2013228","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"2717_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00795-010-0495-2","volume":"44","author":"MM Shao","year":"2011","unstructured":"Shao MM, Liu J, Vong JS, Niu Y, Germin B, Tang P, Chan AW, Lui PC, Law BK, Tan PH et al (2011) A subset of breast cancer predisposes to brain metastasis. Med Mol Morphol 44(1):15\u201320","journal-title":"Med Mol Morphol"},{"issue":"1","key":"2717_CR23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13058-016-0725-1","volume":"18","author":"EH Allott","year":"2016","unstructured":"Allott EH, Geradts J, Sun X, Cohen SM, Zirpoli GR, Khoury T, Bshara W, Chen M, Sherman ME, Palmer JR et al (2016) Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification. Breast Cancer Res 18(1):68","journal-title":"Breast Cancer Res"},{"issue":"Suppl 2","key":"2717_CR24","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.breast.2015.07.015","volume":"24","author":"A Nardone","year":"2015","unstructured":"Nardone A, De Angelis C, Trivedi MV, Osborne CK, Schiff R (2015) The changing role of ER in endocrine resistance. Breast 24(Suppl 2):S60\u2013S66","journal-title":"Breast"},{"issue":"24","key":"2717_CR25","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1158\/1078-0432.CCR-09-0636","volume":"15","author":"PR Pohlmann","year":"2009","unstructured":"Pohlmann PR, Mayer IA, Mernaugh R (2009) Resistance to trastuzumab in breast cancer. Clin Cancer Res 15(24):7479\u20137491","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2717-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T05:57:12Z","timestamp":1543471032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2717-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2717-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]}}}